Cargando…

Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma

Multiple myeloma occurs primarily in elderly patients. Considering the high prevalence of comorbidities, comorbidity is an important issue for the management of myeloma. However, the impact of comorbidity on clinical outcomes has not been fully investigated. We retrospectively analyzed patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung Min, Kim, Moon Jin, Jung, Hyun Ae, Kim, Kihyun, Kim, Seok Jin, Jang, Jun Ho, Kim, Won Seog, Jung, Chul Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119725/ https://www.ncbi.nlm.nih.gov/pubmed/25114902 http://dx.doi.org/10.1155/2014/437852

Ejemplares similares

Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
por: Cho, Jang Ho, et al.
Publicado: (2021)

Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma
por: Lee, Yoo Jin, et al.
Publicado: (2019)

Recalibration and Validation of the Charlson Comorbidity Index in Korean Incident Hemodialysis Patients
por: Park, Jae Yoon, et al.
Publicado: (2015)

Iron deficient erythropoiesis might play key role in development of anemia in cancer patients
por: Park, Silvia, et al.
Publicado: (2015)

Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation
por: Park, Silvia, et al.
Publicado: (2016)

Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
por: Kim, Dae Sik, et al.
Publicado: (2017)

Effectiveness and Safety of Endoscopic Submucosal Dissection for Colorectal Neoplasm in Patients with High Charlson Comorbidity Index Score: A HASID Multicenter Study
por: Kim, Dong-Hyun, et al.
Publicado: (2023)

In Freiburg, um Freiburg, um Freiburg herum /
por: Meckel, Eberhard, 1907-1969
Publicado: (1957)

The Association between Charlson Comorbidity Index and the Medical Care Cost of Cancer: A Retrospective Study
por: Yoon, Seok-Jun, et al.
Publicado: (2015)

Progression of Monoclonal Gammopathy with Undetermined Significance to Multiple Myeloma Diagnosed by Kidney Biopsy: A Case Report
por: Kim, Jin Hae, et al.
Publicado: (2015)

Recalibration and validation of the Charlson Comorbidity Index in acute kidney injury patients underwent continuous renal replacement therapy
por: Lee, Jinwoo, et al.
Publicado: (2022)

Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension
por: Rymkiewicz, Peter, et al.
Publicado: (2016)

Clinical Utility of a Diagnostic Approach to Detect Genetic Abnormalities in Multiple Myeloma: A Single Institution Experience
por: Jung, Hyun Ae, et al.
Publicado: (2018)

Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and (18)F-FDG PET/CT
por: Cho, Hee Jeong, et al.
Publicado: (2021)

Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea
por: Jang, Jun Ho, et al.
Publicado: (2020)

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
por: Song, Ga-Young, et al.
Publicado: (2020)

Recalibration and validation of the Charlson Comorbidity Index in an Asian population: the National Health Insurance Service-National Sample Cohort study
por: Choi, Jae Shin, et al.
Publicado: (2020)

Outcomes of a Modified CALGB 19802 Regimen in Adult Acute Lymphoblastic Leukemia
por: Han, A-Reum, et al.
Publicado: (2008)

Frontline therapy for newly diagnosed patients with multiple myeloma
por: Jung, Sung-Hoon, et al.
Publicado: (2020)

The Prognostic Value of the Charlson's Comorbidity Index in Patients with Prolonged Acute Mechanical Ventilation: A Single Center Experience
por: Song, Seung Eon, et al.
Publicado: (2016)

A Case of Deep Vein Thrombosis and Pulmonary Thromboembolism after Intravenous Immunoglobulin Therapy
por: Lee, Yu-Ji, et al.
Publicado: (2007)

Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Zhang, Yue, et al.
Publicado: (2019)

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)
por: Lee, Ho Sup, et al.
Publicado: (2020)

Association between Charlson comorbidity index and complications of endoscopic resection of gastric neoplasms in elderly patients
por: Kim, Sunmin, et al.
Publicado: (2020)

Relationship between bortezomib-containing regimens and the incidence of tuberculosis in patients with myeloma
por: Kim, Kihyun, et al.
Publicado: (2013)

Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities
por: Jia, Shuangshuang, et al.
Publicado: (2022)

Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension
por: Kim, Hyun-Jin, et al.
Publicado: (2016)

Charlson comorbidity index as a predictor of periodontal disease in elderly participants
por: Lee, Jae-Hong, et al.
Publicado: (2018)

The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma
por: Yoon, Sang Eun, et al.
Publicado: (2023)

Cognitive Function and Neuropsychological Comorbidities in Children with Newly Diagnosed Idiopathic Epilepsy
por: Lee, Seung Yun, et al.
Publicado: (2017)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Wang, Bei, et al.
Publicado: (2022)

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
por: Song, Ga-Young, et al.
Publicado: (2022)

Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen
por: Jung, Sung-Hoon, et al.
Publicado: (2016)

Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma
por: Batsukh, Khishigjargal, et al.
Publicado: (2017)

The Impact of Hyperglycemia on Risk of Severe Infections during Early Period of Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma
por: Jung, Sung-Hoon, et al.
Publicado: (2014)

Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
por: Park, Hyunsung, et al.
Publicado: (2017)

Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients
por: Park, Jae Won, et al.
Publicado: (2018)

The Freiburg Eye Clinic
por: Sprawson, C. A.
Publicado: (1911)

The Charlson Comorbidity Index is associated with risk of 30-day mortality in patients with myocardial injury after non-cardiac surgery
por: Kim, Sojin, et al.
Publicado: (2021)

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy
por: Fink, Christoph A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b2ibrsia8l8af6tn0ppbuttfh1